PHARMACY

NABP announces general registration date for .pharmacy domains

BY David Salazar

MOUNT PROSPECT, Illi. — Some online pharmacy sites will soon be able to point visitors to their .pharmacy domain names. The National Association of Boards of Pharmacy (NABP) announced Thursday that .pharmacy domains will enter general registration for pharmacies and related organizations starting June 3. 
 
The NABP introduced the pharmacy-centered Top-Level Domain (TLD) in 2014 as a way for consumers to clearly distinguish legitimate online pharmacy resources from potentially unsafe and illegal sites. NABP’s review of  about 11,000 sites selling prescriptions drugs found that 96% of them skirt pharmacy standards and laws. Since introducing the TLD, NABP has approved the requests of some 300 entities who applied during the limited registration period for a .pharmacy domain. 
 
Those interested in a .pharmacy domain must apply with an application fee and documentation showing that the organization’s site complies with NABP standards, as well as all the content from the proposed site. Organizations who are approved by the Verified Internet Pharmacy Practice Sites (VIPPS) and its veterinary counterpart (Vet-VIPPS) do not need to submit an application. More information about the .pharmacy TLD can be found at safe.pharmacy
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Camber intros generic Abilify

BY David Salazar

PISCATAWAY, N.J. — Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg strength tablets. 
 
Aripiprazole is used to treat schizophrenia, which affects about 1% of the population, and bipolar disorder. The FDA approved the first round of the generic in late April. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

AARP report: Decreases in generics prices are slowing down

BY David Salazar

WASHINGTON — The AARP Public Policy Institute’s latest Rx Price Watch Report shows that, despite an overall 4% decrease in price in 2013, the prices of generic drugs seem to be dropping at the slowest rate since 2006. 
 
The report, which examined the prices of 280 widely used generic drugs, found that even though a majority saw a price decrease, more than a quarter of them increased in price. Among those that increased in price, some 11 medications had price increases over 30 percent. 
 
In the case of bacterial infection and acne treatment doxycycline hyclate, the price of 100 mg capsules and tablets increased over 1,000 percent. Rheumatoid arthritis medication methotrexate 2.5 mg tablets  increased in price over 250%. 
 
With generics constituting more than 75% of U.S. retail prescriptions, those who rely on generics — particularly elderly patients — will feel the impact of these increases, as well as the slower rate of cost decrease, in their wallets.
 
“Declining generic drug prices have helped many Americans’ pocketbooks, particularly older adults on fixed incomes,” AARP’s VP, policy, Debra Whitman said. “Unfortunately, recent trends indicate that we may not be able to rely on these savings forever.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?